UBS analyst Peter Grom reiterated a Neutral rating on Clorox (NYSE:CLX) stock with a steady price target of $176.00. Grom ...

The Clorox Company (NYSE:CLX), with a portfolio of well-known brands such as Brita, Burt's Bees, and Pine-Sol, has been a pioneer in integrating Environmental, Social, and Governance (ESG) factors ...

Clorox (NYSE:CLX – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on Monday, February 3rd. Analysts expect the company to announce earnings of $1.39 per ...

Barclays lowered the firm’s price target on Clorox (CLX) to $130 from $139 and keeps an Underweight rating on the shares as part of a consumer ...

CLX looks poised for growth through recent recovery, improved distribution channels and focus on innovation and expansion ...

Janney Montgomery Scott LLC lifted its stake in The Clorox Company (NYSE:CLX – Free Report) by 7.9% during the fourth quarter ...

Observing a 6.78% increase, the current average has risen from the previous average price target of $145.43. The analysis of recent analyst actions sheds light on the perception of Clorox by ...

As previously reported on Tuesday, Wells Fargo upgraded Clorox (CLX) to Equal Weight from Underweight with a price target of $157, up from $155. While the firm says it continues to struggle with ...

Clorox divested its Better Health Vitamins, Minerals and Supplements VMS business. This highlights an important step in the evolution of its portfolio, supporting CLX’s target to lower ...